Scientists find new clues to GSK's Pandemrix's narcolepsy issue
This article was originally published in Scrip
Executive Summary
Scientists are building a theory that may account for GlaxoSmithKline's Pandemrix flu vaccine's association with narcolepsy during the 2009-10 swine flu A(H1N1) pandemic. The findings published in Science Translational Medicine may help prevent similar problems with future vaccines.